PCN73 Economic Analysis of the Use of Crizotinib, a Tyrosine Kinase ALK Inhibitor, in the Treatment of ALK Positive Non-Small Cell Lung Cancer in the Mexican Setting
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2113
https://www.valueinhealthjournal.com/article/S1098-3015(12)03827-2/fulltext
Title :
PCN73 Economic Analysis of the Use of Crizotinib, a Tyrosine Kinase ALK Inhibitor, in the Treatment of ALK Positive Non-Small Cell Lung Cancer in the Mexican Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03827-2&doi=10.1016/j.jval.2012.08.2113
First page :
A422
Section Title :
Cancer
Open access? :
No
Section Order :
766